Oxidized mtDNA Contributes to Pulmonary Inflammation and Fibrosis in Bleomycin‐Induced Lung Injury
MedComm · 2026-04 · 7 (4)
DOI: 10.1002/mco2.70664 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 02.04.2026. Verfasst von Ye Mao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Centre for Geriatrics West China …. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pulmonary fibrosis is a chronic and progressive interstitial lung disease with limited treatment options aside from lung transplantation. Bleomycin (BLM)‐induced lung injury is the most commonly used experimental model to mimic the key pathological features of human pulmonary fibrosis, which include an early inflammatory phase and a later fibrotic phase. Neutrophil infiltration and M2 macrophage activation are key events in these stages, respectively. However, the molecular mechanisms by which BLM triggers pulmonary inflammation and fibrosis remain incompletely understood. In this study, we found that BLM treatment induced ROS‐mediated oxidative damage in the lungs, leading to an inflammatory microenvironment and the release of oxidized mitochondrial DNA (oxid‐mtDNA). Oxid‐mtDNA was shown to contribute to the early inflammatory response by promoting neutrophil recruitment and enhancing macrophage polarization, which subsequently drove tissue remodeling and fibrosis. Notably, direct injection of oxid‐mtDNA into the lungs recapitulated the fibrotic features observed in the BLM model. Furthermore, studies using STING‐ and NLRP3‐deficient mice demonstrated that loss of either pathway significantly attenuated BLM‐induced inflammation and fibrosis, implicating their involvement downstream of oxid‐mtDNA signaling. Collectively, our findings identify oxid‐mtDNA as a critical mediator linking oxidative injury to immune activation and fibrotic remodeling in the lung, offering new insights into pulmonary fibrosis pathogenesis and potential therapeutic targets.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Centre for Geriatrics West China Hospital, Sichuan University Chengdu Sichuan P.R. China.
- Department of Oncology The Second Affiliated Hospital of Nanchang University Nanchang China.
- Department of Biotherapy, Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University.
ORCID-Profile: Xiawei Wei
Zitieren
APA
Mao, Y., Tian, X., Ai, J., Zhou, X., Ni, Y., Wan, D., Luo, M., & Wei, X. (2026). Oxidized mtDNA Contributes to Pulmonary Inflammation and Fibrosis in Bleomycin‐Induced Lung Injury. MedComm, 7(4). https://doi.org/10.1002/mco2.70664
Vancouver
Mao Y, Tian X, Ai J, Zhou X, Ni Y, Wan D, et al. Oxidized mtDNA Contributes to Pulmonary Inflammation and Fibrosis in Bleomycin‐Induced Lung Injury. MedComm. 2026;7(4). doi:10.1002/mco2.70664
BibTeX
@article{Mao2026,
author = {Mao, Ye and Tian, Xinyu and Ai, Jiayuan and Zhou, Xiaoting and Ni, Yanghong and Wan, Dandan and Luo, Min and Wei, Xiawei},
title = {Oxidized mtDNA Contributes to Pulmonary Inflammation and Fibrosis in Bleomycin‐Induced Lung Injury},
journal = {MedComm},
year = {2026},
volume = {7},
number = {4},
doi = {10.1002/mco2.70664}
}
EUVIMED